- Home
- Articles
-
10.5606/tgkdc.dergisi.2017.14362
The eighth staging system of non-small cell lung cancer and its practical implications
Akif Turna1, Güntülü Ak2, Berna Eren Kömürcüoğlu3, Sibel Yurt4, Ülkü Yılmaz5
1İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Göğüs Cerrahisi Anabilim Dalı, İstanbul, Türkiye
2Eskişehir Osmangazi Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Eskişehir, Türkiye
3İzmir Dr. Suat Seren Göğüs Hastalıkları ve Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, İzmir, Türkiye
4Yedikule Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, İstanbul, Türkiye
5Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, Ankara, Türkiye
DOI : 10.5606/tgkdc.dergisi.2017.14362
Staging is an essential part of the approach to patients with
lung cancer. The primary goal of the tumor classification
is to correctly describe the anatomic extent of the disease.
The anatomic extent of the tumor has a major impact
on the treatment selection and prognosis. The general
approach to patients with non-small cell lung cancer
include mediastinal staging and non-thoracic staging
methods, history and physical examination, imaging,
minimally invasive techniques, and invasive surgical
techniques. The current lung cancer staging system is the
eighth edition of the tumor, node, and metastasis (TNM)
classification, which was took effect in January 2017. In
this article, staging methods and the definitions for current
T, N, M descriptors and the stage groups in non-small cell
lung cancer are reviewed. New definitions of T, N, and M
factors seem to better indicate the most optimal treatment
option for an individual patient and to better predict the
survival in patients.
Keywords : Eight staging system; lung cancer; M factor; N factor; T factor
Viewed : 6533
Downloaded : 3486